Pregnancy in Effectiveness Trials of HIV Prevention Agents
- 1 December 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 34 (12) , 1035-1039
- https://doi.org/10.1097/olq.0b013e3180e90586
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective studyThe Lancet, 2005
- Sensitivity of Over-the-Counter Pregnancy Tests: Comparison of Utility and Marketing MessagesJournal of the American Pharmacists Association, 2005
- Vaginal microbicides: A novel approach to preventing sexual transmission of HIVCurrent HIV/AIDS Reports, 2004
- Human chorionic gonadotropin in maternal serum in relation to fetal gender and utero‐placental blood flowActa Obstetricia et Gynecologica Scandinavica, 2004
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialThe Lancet, 2002
- Effect of Nonoxynol-9 Gel on Urogenital Gonorrhea and Chlamydial InfectionJAMA, 2002
- Evaluation of a Low-Dose Nonoxynol-9 Gel for the Prevention of Sexually Transmitted DiseasesSexually Transmitted Diseases, 2001
- A Controlled Trial of Nonoxynol 9 Film to Reduce Male-to-Female Transmission of Sexually Transmitted DiseasesNew England Journal of Medicine, 1998
- Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infectionsThe Lancet, 1992
- A Clinical Trial of Nonoxynol-9 for Preventing Gonococcal and Chlamydial InfectionsThe Journal of Infectious Diseases, 1988